Skyworks completes $22bn Qorvo combination as semiconductor consolidation creates broader RF and power platform
IES Holdings completes $691m DBM Global acquisition as structural steel and data center exposure expands
Read More Pharma Industry News Imugene (ASX:IMU) jumps 19% as azer-cel opportunity meets a funding reset Imugene Limited shares jumped 18.92% to A$0.044 on October 5 as trading activity accelerated from a 52-week low. The rebound puts azer-cel, Imugene's sharply reduced cost base and its recently replenished funding runway back in focus. bySrinathOctober 5, 2026